US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 2.000
  • -0.150-6.98%
Close Apr 1 16:00 ET
  • 2.100
  • +0.100+5.00%
Post 18:36 ET
128.06MMarket Cap-1.52P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Larimar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Larimar Therapeutics Earnings Reports

  • Larimar Therapeutics | 10-K: FY2024 Annual Report

    Mar 24 16:52 ET

  • Larimar Therapeutics | 8-K: Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results

    Mar 24 07:04 ET

  • Larimar Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 30, 2024 17:07 ET

  • Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results

    Oct 30, 2024 07:07 ET

    • Read more

    Market Insights

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    OKAY
    833230
    +29.96%
    CHANGFU CO.,LTD
    871396
    +24.59%
    Gansu Longshenrongfa Pharmaceutical Industry
    300534
    +20.05%
    4
    Tibet Duo Rui Pharmaceutical
    301075
    +20.02%
    5
    Chengda Pharmaceuticals
    301201
    +20.01%
    Log In for the Full List
    Unlock Now

    Investment Course

    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

    Trump's comeback to the Office

    Following Trump's Policies to Seek Investment Opportunities

    Discussing

    Chinese stock earnings surge: Will profit sustain the rally?
    1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
    China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings